Заключение

Трансгенные линии Drosophila воспроизводят многие ключевые признаки НДЗ. В то же время, не следует ожидать, что на этих моделях будут полностью повторены все особенности болезней человека.

Литература

Большакова О.И., Жук А.А., Родин Д.И. и др. Влияние гиперэкспрессии гена АРР человека на холинергические и дофаминергические нейроны Drosophila melanogaster // Экологическая генетика. 2013. Т XI. № 1. С.23-31.

Иллариошкин С.Н. Конформационные болезни мозга. М.: Янус-К, 2003. 246 с.

Adams M.D., Sekelsky J.J. From sequence to phenotype: reverse genetics in Drosophila melanogaster // Nat. Rev. Genet. 2002. Vol. 3. P 189-198.

Aguzzi A., Baumann F., Bremer J. The Prion’s Elusive Reason for Being // Annu. Rev. Neurosci. 2008. Vol. 31. P. 439-477.

Andersson K., Pokrzywa M., Dacklin I., Lundgren E. Inhibition of TTR aggregation-induced cell death--a new role for serum amyloid P component // PLoS One. 2013. Vol. 8. P. e55766.

Ashley J., Packard M. Ataman B., Budnik V. Fasciclin II signals new synapse formation through amyloid precursor protein and the scaffolding protein dX11/Mint // J. Neurosci. 2005. Vol. 25. P. 5943-5955.

Baki L., Shioi J., Wen P. et al. PS1 activates PI3K thus inhibiting GSK-3 activity and tau overphosphorylation: effects of FAD mutations // EMBO J.

Bellen H.J., Levis R.W., Liao G. et al. The BDGP gene disruption project: single transposon insertions associated with 40% of Drosophila genes // Genetics. 2004. Vol. 167. P 761-781.

Bentahir M., Nyabi O.,Verhamme J. et al. Presenilin clinical mutations can affect c-secretase activity by different mechanisms // J. Neurochem. 2006. Vol. 96. P. 732-742.

Berg I., Thor S., Hammarstrom P. Modeling familial amyloidotic polyneuropathy (Transthyretin V30M) in Drosophila melanogaster // Neurodegener. Dis. 2009. Vol.6. P 127-38.

Bier E. Drosophila, the golden bug, emerges as a tool for human genetics // Nat. Rev. Genet. 2005. Vol. 6. P. 9-23.

Bilen J., Bonini N.M. Drosophila as a model for human neurodegenerative disease // Annu. Rev. Genet. 2005. Vol.39. P 153-171.

Brand A.H., Perrimon N. Targeted gene expression as a means of altering cell fates and generating dominant phenotypes // Development. 1993. Vol. 118. P. 401-415.

Brown P., Gibbs C.J., Rodgers-Johnson P. et al. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease // Ann. Neurol. 1994. Vol. 35. P 513-529.

Buxbaum J.N., Ye Z., Reixach N. et al. Transthyretin protects Alzheimer’s mice from the behavioral and biochemical effects of Abeta toxicity // Proc. Natl. Acad. Sci. USA. 2008. Vol. 105. P. 2681-2686.

Cao W., Song H.J., Gangi T. et al. Identification of novel genes that modify phenotypes induced by Alzheimer’s beta-amyloid overexpression in Drosophila // Genetics. 2008. Vol. 178. P. 1457-1457.

Carmine-Simmen K., Proctor T., Tschape J. et al. Neurotoxic effects induced by the Drosophila amyloid-beta peptide suggest a conserved toxic function // Neurobiol. Dis. 2009. Vol. 33. P. 274-281.

Chakraborty R., Vepuri V., MhatreS.D. et al. Characterization of a Drosophila Alzheimer’s disease model: pharmacological rescue of cognitive defects // PLoS One. 2011. Vol. 6. P. e20799.

Chiang H.C., Iijima K., Hakker I., Zhong Y.

Chiang H.C., Wang L., Xie Z. et al. PI3 kinase signaling is involved in Abeta-induced memory loss in Drosophila // Proc. Natl. Acad. Sci. USA. 2010. Vol. 107. P. 7060-7065.

Choi S.H., Leight S.N., Lee V.M. et al. Accelerated Abeta deposition in APPswe/PS1deltaE9 mice with hemi- zygous deletions of TTR (transthyretin) // J. Neurosci. 2007. Vol. 27. P. 7006-7010.

Connors L.H., Lim A., Prokaeva T. et al. Tabulation of human transthyretin (TTR) variants // Amyloid. 2003. Vol. 10. P. 160-184.

Crowther D.C., Kinghorn K.J., Miranda E. et al. Intraneuronal Abeta, nonamyloid aggregates and neurodegeneration in a Drosophila model of Alzheimer’s disease // Neuroscience. 2005. Vol. 132. P. 123-135.

Deleault N.R., Dolph P.J., Feany M.B. et al. Post-transcriptional suppression of pathogenic prion protein expression in Drosophila neurons // J. Neurochem. 2003. Vol. 85. P. 1614-1623.

De Strooper B., Annaert W. Proteolytic processing and cell biological functions of the amyloid precursor protein // J. Cell Sci. 2000. Vol. 113. P. 1857-1870.

De Strooper B.D., Annaert W. Presenilins and the intramembrane proteolysis of proteins: facts and fiction // Nat. Cell. Biol. 2001. Vol. 3. P. 221-25.

ElliottD., BrandH. The GAL4 System. A versatile system for the expression of genes. Methods in molecular Biology: Drosophila: Methods and Protocols. Ed. C. Dahmann. Humana. Totowa, NY: Press Inc., 2008. P. 79-85.

Enerly E., Larsson J., Lambertsson A. Reverse genetics in Drosophila: from sequence to phenotype using UAS-RNAi transgenic flies // Genesis. 2002. Vol. 34. P. 152-155.

Fernandez-Funez P., Casas-Tinto S., Zhang Y. et al. In vivo generation of neurotoxic prion protein: role for hsp70 in accumulation of misfolded isoforms // PLoS Genet. 2009. Vol. 5. P. e1000507.

Finelli A., Kelkar A., Song H.-J. et al. A model for studying Alzheimer’s AB42-induced toxicity in Drosophila melanogaster // Mol.

Fortini M.E., SkupskiM.P., BoguskiM.S., Hariharan I.K. A survey of human disease gene counterparts in the Drosophila genome // J. Cell. Biol. 2000. Vol. 150. P. 23-30.

Gavin B.A., Dolph M.J., Deleault N.R. et al. Accelerated accumulation of misfolded prion protein and spongiform degeneration in a Drosophila model of Gerstmann- Straussler-Scheinker syndrome // J. Neurosci. 2006. Vol. 26. P. 12408-12414.

Giacomotto J., Segalat L. High-throughput screening and small animal models, where are we? // Br. J. Pharmacol. 2010. Vol. 160. P. 204-216.

Goodman D. Retinoids and retinol-binding proteins // Harvey Lect. 1987. Vol. 81. P. 111-132.

Greeve I., Kretzschmar D., Tschape J.A. et al. Age-dependent neurodegeneration and Alzheimer-amyloid plaque formation in transgenic Drosophila // J. Neurosci. 2004. Vol. 24. P. 3899-3906.

Gunawardena S., Goldstein L.S. Disruption of axonal transport and neuronal viability by amyloid precursor protein mutations in Drosophila // Neuron. 2001. Vol. 32. P. 389-401.

Haass C., Selkoe D.J. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer’s amyloid beta-peptide // Nat. Rev. Mol. Cell. Biol. 2007. Vol. 8. P. 101-112.

Han D.D., Stein D., Stevens L.M. Investigating the function of follicular subpopulations during Drosophila oogenesis through hormone-dependent enhancer-targeted cell ablation // Development. 2002. Vol. 127. P. 573-583.

Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics // Science. 2002. Vol. 297. P. 353-356.

Hirai K., Aliev G., Nunomura A. et al. Mitochondrial abnormalities in Alzheimer’s disease // J. Neurosci. 2001. Vol. 21. P. 3017-3023.

Hirth F. Drosophila melanogaster in the study of human neurodegeneration // CNS Neurol. Disord. Drug. Targets. 2010. Vol. 9. P. 504-23.

Huet F., Lu J.T., Myrick K.V et al. A deletion-generator compound element allows deletion saturation analysis for genomewide phenotypic annotation // Proc.

Iijima K., Liu H.-P., ChiangA.-S. et al. Dissecting the pathological effects of human Ap40 and Ap42 in Drosophila: A potential model for Alzheimer’s disease // PNAS. 2004. Vol. 101. P. 6623-6628.

Iijima K., Chiang H.C., Hearn S. A. et. al. Abeta42 mutants with different aggregation profiles induce distinct pathologies in Drosophila // PLoS One. 2008. Vol. 1-9. P. е1703.

Iijima-Ando K., Iijima K. Transgenic Drosophila models of Alzheimer’s disease and tauopathies // Brain. Struct. Funct. 2010. Vol. 214. P 245-262.

Iijima-Ando K., Hearn S.A., Shenton C. et al. Mitochondrial Mislocalization Underlies Ab42-Induced Neuronal Dysfunction in a Drosophila Model of Alzheimer’s Disease // PLoS One. 2009. Vol. 4. P. e8310.

Iwata N., Tsubuki S., Takaki Y. et al. Metabolic regulation of brain Ah by neprilysin // Science. 2001. Vol. 292. P 1550-1552.

Iwata N., Higuchi M., Saido T. Metabolism of amyloid-P peptide and Alzheimer’s disease // Pharmacology & Therapeutics. 2005. Vol. 108. P 129-148.

Jang H., Arce F.T., Ramachandran S. et al. Truncated beta-amyloid peptide channels provide an alternative mechanism for Alzheimer’s Disease and Down syndrome // Proc. Natl. Acad. Sci. USA. 2010. Vol. 107. P. 6538-6543.

Kazazian H.H. Mobile elements: drivers of genome evolution // Science. 2004. Vol. 303. P 1626-1632.

Krasemann S., Zerr I., Weber T. et al. Prior disease associated with a bovel nine octapeptide repeat insertion in the PRNP gene // Brain Res. Vol. Brain Res. 1995. Vol. 34. P. 173-176.

Liu L., Murphy R.M. Kinetics of inhibition of beta-amyloid aggregation by transthyretin // Biochemistry. 2006. Vol. 45. P 15702-15709.

Liz M.A., Fleming C.E., Nunes A.F. et al. Substrate specificity of transthyretin: identification of natural substrates in the nervous system // Biochem. J. 2009. Vol. 419. P. 467-474.

Lu B., VogelH. Drosophila models of neurodegenerative diseases // Annu. Rev. Pathol.

Luo L.Q., Martin-Morris L.E., White K. Identification, secretion, and neural expression of APPL, a Drosophila protein similar to human amyloid protein precursor // J. Neurosci. 1990. Vol. 10. P 3849-3861.

Luo L., Tully T., White K. Human amyloid precursor protein ameliorates behavioral deficit of flies deleted for Appl gene // Neuron. 1992. Vol. 9. P. 59-605.

Marsh J.L., Thompson LM. Drosophila in the study of neurodegenerative disease // Neuron. 2006. Vol. 52. P 169-78.

Matsumoto K., Toh-eA., Oshima,Y. Genetic control of galactokinase synthesis in Saccharomyces cerevisiae: evidence for constitutive expression of the positive regulatory gene gal4 // J. Bacteriol. 1978. Vol. 134. P. 446-457.

McGuire S.E., Le P. T., Osborn A.J. et al. Spatiotemporal rescue of memory dysfunction in Drosophila // Science. 2003. Vol. 302. P 1765-1768.

MeadS. Prion disease genetics // Eur. J. Hum. Genet. 2006. Vol. 14. P. 273-281.

Metaxakis A., Oehler S., Klinakis A., Savakis C. Minos as a genetic and genomic tool in Drosophila melano- gaster // Genetics. 2005. Vol. 171. P 571-581.

Moloney A., Sattelle D.B., Lomas D.A., Crowther D.C. Alzheimer’s disease: insights from Drosophila mela- nogaster models // Trends Biochem. Sci. 2010. Vol. 35. P. 228-235.

Mullane K., Williams M. Alzheimer’s therapeutics: continued clinical failures question the validity of the amyloid hypothesis-but what lies beyond? // Biochem. Pharmacol. 2013. Vol. 85. P. 289-305.

Myrick K.V., HuetF., Mohr S.E. et al. Large-scale functional annotation and expanded implementations of the P{wHy} hybrid transposon in the Drosophila melanogaster genome // Genetics. 2009. Vol. 182. P. 653-660.

Nagai Y., Fujikake N., Ohno K. et al. Prevention of polyglutamine oligomerization and neurodegeneration by the peptide inhibitor QBP1 in Drosophila // Hum. Mol. Genet. 2003. Vol. 12. P. 1253-1259.

Nicholson L., Singh G.K., Osterwalder T. et al. Spatial and temporal control of gene expression in Drosophila using the inducible GeneSwitch GAL4 system. I. Screen for larval nervous system drivers // Genetics. 2008. Vol. 178. P 215-234.

Olofsson A., Ippel H.J., Baranov V et al. Capture of a dimeric intermediate during transthyretin amyloid formation // J. Biol. Chem. 2001. Vol. 276. P 39592-39599.

Osterwalder T., Yoon K.S., White B.H. Keshishian H. A conditional tissue-specific transgene expression system using inducible GAL4 // Proc. Natl. Acad. Sci. USA. 2001. Vol. 98. P 596-612.

Pandey U.B., Nichols C.D. Human disease models in Drosophila melanogaster and the role of the fly in therapeutic drug discovery // Pharmacol. Rev. 2011. Vol. 63. P. 411-436.

Pokrzywa M., Dacklin I., Hultmark D., Lundgren E. Misfolded transthyretin causes behavioral changes in a Drosophila model for transthyretin-associated amyloidosis // Eur. J. Neurosci, 2007. Vol. 26. P. 913-924.

Pokrzywa M., Dacklin I., VestlingM. et al. Uptake of aggregating transthyretin by fat body in a drosophila model for TTR-associated amyloidosis // PLoS One. 2010. Vol. 5. Р. e14343.

PrusinerS.B. Prions // PNAS. 1998a. Vol. 95. P. 13363-13383.

PrusinerS.B. The prion diseases // Brain Pathol. 1998b. Vol. 8. P. 499-513.

Prusiner S.B., Hsiao K.K. Human prion diseases // Ann. Neurol. 1994. Vol. 35. P. 385-395.

Raeber A.J., Muramoto T., Kornberg T.B., Prusiner S.B. Expression and targeting of Syrian hamster prion protein induced by heat shock in transgenic Drosophila melanogaster // Mech. Dev. 1995. P. 317-327.

Reiter L.T., Potocki L., Chien S. et al. A systematic analysis of human disease-associated gene sequences in Drosophila melanogaster // Genome Res. 2001. Vol. 11. P. 1114-1125.

Rodnguez-Martinez A.B., Garrido J.M., Zarranz J.J. et al. A novel form of human disease with a protease- sensitive prion protein and heterozygosity methionine/valine at codon 129: Case report // BMC Neurol. 2010. Vol. 10. doi: 10.1186/1471-2377-10-99.

Roman G., Endo K., ZongL., DavisR.L. P[Switch], a system for spatial and temporal control of gene expression in Drosophila melanogaster // Proc. Natl. Acad. Sci. USA. 2001. Vol. 98. P. 602-607.

R0rth P. A modular misexpression screen in Drosophila detecting tissue-specific phenotypes // Proc. Natl. Acad. Sci. USA. 1996. Vol. 93. P. 12418-12422.

Rosen D.R., Martin-Morris L., Luo L., White K.A. Drosophila gene encoding a protein resembling the human b-amyloid protein precursor // Proc. Natl. Acad. Sci. USA. 1989. Vol. 86. P. 2478-2482.

SangT.K., Jackson G.R. Drosophila models ofneurodegenerative disease // NeuroRx. 2005. Vol. 2. P. 438-446. Sarantseva S., Timoshenko S., Bolshakova O. et al. Apolipoprotein E-mimetics inhibit neurodegeneration and restore cognitive functions in a transgenic Drosophila model of Alzheimer’s disease // PLoS One. 2009a. Vol. 4. № 12. P. e8191.

Sarantseva S., Bolshakova O., Timoshenko S. et al. Overexpression of human amyloid precursor protein causes neurodegeneration and loss of synaptic proteins in transgenic Drosophila // New Trends in Alzheimer and Parkinson Disorders: ADPD. Eds. Hanin I., Fisher A. Prague: Czech Republic: Medimont, 2009b. P. 245-248.

Saura C., Choi S.-Y., Beglopoulos V et al. Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration // Neuron. 2004. Vol. 42. P. 23-36.

Schwarzman A.L., Gregori L., Vitek M.P. et al. Transthyretin sequesters amyloid beta protein and prevents amyloid formation // Proc. Natl. Acad. Sci. USA. 1994. Vol. 91. P. 8368-8372.

Schwarzman A.L., Singh N., Tsiper M. et al. Endogenous presenilin 1 redistributes to the lamellipodia upon adhesion of Jurkat cells to a collagen matrix // Proc. Natl. Acad. Sci. USA. 1999. Vol. 96. P. 7932-7937.

Selkoe D.J. The cell biology of P-amyloid precursor protein and presenilin in Alzheimer’s disease // Trends Cell. Biol. 1998. Vol. 8. P. 447-453.

Selkoe D.J. Translating cell biology into therapeutic advances in Alzheimer’s disease // Nature. 1999. Vol. 399. P. 23-31.

Singh N., Tsiper M., Romanov V et al. The role of Alzheimer’s disease-related presenilin 1 in intercellular adhesion // Exp. Cell. Res. 2001. Vol. 263. P. 1-13.

Smith D., Wohlgemuth J., Calvi B.R. et al. Hobo enhancer trapping mutagenesis in Drosophila reveals an insertion specificity different from P elements // Genetics. 1993. Vol. 135. P. 1063-1076.

Staudt N., Molitor A., Somogyi K. et al. Gain-of-function screen for genes that affect Drosophila muscle pattern formation // PLoS Genet. 2005. Vol. 1. P. e55.

Tateishi J., Kitamoto T. Inherited prion diseases and transmission to rodents // Brain. Pathol. 1995. Vol. 5. P. 53-59.

Torroja L., Chu H., KotovskyI., White K. Neuronal overexpression of APPL, the Drosophila homologue of the amyloid precursor protein (APP), disrupts axonal transport // Curr. Biol. 1999a. Vol. 9. P. 489-492.

Torroja L., Packard M., Gorczyca M. et al. The Drosophila beta-amyloid precursor protein homolog promotes synapse differentiation at the neuromuscular junction // J Neurosci. 1999b. Vol. 19. P. 7793-7803.

Van de Hoef D.L., Hughes J., Livne-Bar I. et al. Identifying genes that interact with Drosophila presenilin and amyloid precursor protein // Genesis. 2009. Vol. 47. P. 246-260.

Walsh D.M., Selkoe D.J. Deciphering the molecular basis of memory failure in Alzheimer’s disease // Neuron. 2004. Vol. 44. P. 181-193.

WestermarkP., Sletten K., Johansson B., Cornwell G.G. 3rd. Fibril in senile systemic amyloidosis is derived from normal transthyretin // Proc. Natl. Acad. Sci. USA. 1990. Vol. 87. P. 2843-2845.

Woeber K.A., Ingbar S.H. The contribution of thyroxinebinding prealbumin to the binding of thyroxine in human serum, as assessed by immunoadsorption // J. Clin. Invest. 1968. Vol. 47. P. 1710-1721.

Yagi Y., Tomita S., Nakamura M., Suzuki T. Overexpression of human amyloid precursor protein in Drosophila // Mol. Cell. Biol. Res. Commun. 2000. Vol. 4. P. 43-49.

Ye Y., FortiniM.E. Characterization of Drosophila presenilin and its colocalization with Notch during development // Mech. Dev. 1998. Vol. 79. P. 199-211.

Zhao X.L., Wang W.A., Tan J.X. et al. Expression of beta-amyloid induced age-dependent presynaptic and axonal changes in Drosophila // J. Neurosci. 2010. Vol. 20. P. 1512-1522.

Zou W.Q., Puoti G., Xiao X. et al. Variably protease-sensitive prionopathy: a new sporadic disease of the prion protein // Ann. Neurol. 2010. Vol. 68. P. 162-172.